Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Change in Account Payables (2020 - 2023)

Cullinan Therapeutics has reported Change in Account Payables over the past 4 years, most recently at $1.5 million for Q4 2023.

  • Quarterly results put Change in Account Payables at $1.5 million for Q4 2023, up 34.67% from a year ago — trailing twelve months through Dec 2023 was -$167000.0 (up 67.19% YoY), and the annual figure for FY2025 was -$839000.0, down 3.33%.
  • Change in Account Payables for Q4 2023 was $1.5 million at Cullinan Therapeutics, up from -$1.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CGEM hit a ceiling of $4.5 million in Q4 2020 and a floor of -$4.1 million in Q1 2021.
  • Median Change in Account Payables over the past 4 years was $315500.0 (2020), compared with a mean of $4375.0.
  • Biggest five-year swings in Change in Account Payables: crashed 2525.88% in 2021 and later soared 176.07% in 2022.
  • Cullinan Therapeutics' Change in Account Payables stood at $4.5 million in 2020, then crashed by 74.65% to $1.1 million in 2021, then changed by 0.0% to $1.1 million in 2022, then skyrocketed by 34.67% to $1.5 million in 2023.
  • The last three reported values for Change in Account Payables were $1.5 million (Q4 2023), -$1.5 million (Q3 2023), and $461000.0 (Q2 2023) per Business Quant data.